Sepracor
AcquiredMarlborough, United States · Founded 1984 · $10.5M raised
- Headquarters
- Marlborough, Massachusetts
- Employees
- 501–1000
- Founded
- 1984
- Business Model
- B2B
- Website
- sunovion.com
- Total Funding
- $10.5M
- Last Round
- $10.0M Venture RoundJun 1993
- Rounds
- 2
About
Bioactive membranes and other separation technologies for the chemical processing and pharmaceutical fields
Summary
Sepracor is a Drug Discovery company based in Marlborough, United States, founded in 1984. It has raised $10.5M in total across 2 rounds, most recently a $10.0M Venture Round round in Jun 1993. Investors include Dainippon Sumitomo Pharma, Marion Merrell Dow and Lehman Brothers.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2009
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.